Boston Sci Wins Latest TAVR Patent Dispute Against Edwards

The European Patent Office sided with Boston Scientific on April 16 in agreeing to revoke an Edwards Lifesciences patent on a technology used in transcatheter aortic valve replacement (TAVR) devices.

More from Legal & IP

More from Policy & Regulation